Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on May 26, 2026

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Next Hour Garage Door Repair Expands Same-Day Service Across Santa Clarita
From 48,000 CVEs to 256 Real Threats: New Research Calls for Smarter Cyber Defense
Avaturn Releases AVTR-1: First Open-Weights AI Avatar Duplex Model
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
Asset Workflows Secures Major Strategic Investment to Accelerate Growth Across Sectors and Regions
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Belo Sun Announces 2026 Shareholder Meeting Voting Results and Corporate Update
Evolution Metals & Technologies Corp. Regains Compliance with Nasdaq Listing Rule Following Previously Received Notice and Filing of Quarterly Report on Form 10-Q
H33 OFFERS FREE POST-QUANTUM CRYPTOGRAPHIC CONVERSION FOR FIRST 1,000 COMPANIES
NANOBIOTIX Announces Closing of Global Offering
Global Mofy AI Limited Announces Closing of $8 Million Registered Offering
Atico Reports Consolidated Financial Results for the First Quarter of 2026
Pasqal and Bleichroeder Acquisition Corp. II Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
Microchip Technology to Present at the TD Cowen 54th Annual Technology, Media & Telecom Conference
Spyre Therapeutics to Participate in Upcoming June Investor Conferences
AGM Group Receives Notification from Nasdaq Regarding Delayed Filing of Form 20-F
SPS Commerce to Present at the William Blair 46th Annual Growth Stock Conference
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.